189 related articles for article (PubMed ID: 29050840)
1. Recommendations for the use of methotrexate in psoriatic arthritis.
Cañete JD; Ariza-Ariza R; Bustabad S; Delgado C; Fernández-Carballido C; García Llorente JF; Loza E; Montilla C; Naranjo A; Pinto JA; Queiro R; Ramírez J; Tornero-Molina J
Reumatol Clin (Engl Ed); 2018; 14(4):183-190. PubMed ID: 29050840
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for the use of parenteral methotrexate in rheumatic diseases.
Tornero Molina J; Calvo Alen J; Ballina J; Belmonte MÁ; Blanco FJ; Caracuel MÁ; Carbonell J; Corominas H; Chamizo E; Hidalgo C; Ivorra JR; Marenco JL; Moreno Muelas JV; Muñoz-Fernández S; Nolla JM; Pérez T; Sanmarti R; Trenor P; Urrego C; Vidal J; Rosas Gomez de Salazar J
Reumatol Clin (Engl Ed); 2018; 14(3):142-149. PubMed ID: 28082032
[TBL] [Abstract][Full Text] [Related]
3. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis.
Tornero-Molina J; Alperi-López M; Castellví I; de Agustín-de Oro JJ; Escudero A; García-Vicuña R; González-Gay MÁ; Hidalgo C; Rubio E; Sanmartí R; Casamira N; Calvo-Alén J
Reumatol Clin (Engl Ed); 2022 Jan; 18(1):33-41. PubMed ID: 35090610
[TBL] [Abstract][Full Text] [Related]
4. Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis.
Tornero Molina J; Balsa Criado A; Blanco García F; Blanco Alonso R; Bustabad S; Calvo Alen J; Corominas H; Fernández Nebro A; Román Ivorra JA; Sanmartí R
Reumatol Clin (Engl Ed); 2020; 16(4):272-281. PubMed ID: 30098882
[TBL] [Abstract][Full Text] [Related]
5. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis.
Tornero-Molina J; Alperi-López M; Castellví I; de Agustín-de Oro JJ; Escudero A; García-Vicuña R; González-Gay MÁ; Hidalgo C; Rubio E; Sanmartí R; Casamira N; Calvo-Alén J
Reumatol Clin (Engl Ed); 2020 Oct; ():. PubMed ID: 33041228
[TBL] [Abstract][Full Text] [Related]
6. Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.
García-Vicuña R; Garrido N; Gómez S; Joven B; Queiro R; Ramírez J; Rebollo F; Loza E; Sellas A
Rheumatol Int; 2021 Sep; 41(9):1549-1565. PubMed ID: 33934175
[TBL] [Abstract][Full Text] [Related]
7. Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.
Torre Alonso JC; Díaz Del Campo Fontecha P; Almodóvar R; Cañete JD; Montilla Morales C; Moreno M; Plasencia-Rodríguez C; Ramírez García J; Queiro R
Reumatol Clin (Engl Ed); 2018; 14(5):254-268. PubMed ID: 29111261
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review.
Ruhoff JT; Horn HC; Ellingsen T
Dan Med J; 2019 Oct; 66(10):. PubMed ID: 31571573
[TBL] [Abstract][Full Text] [Related]
9. Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
Mulder MLM; Vriezekolk JE; den Broeder N; Mahler EAM; Helliwell PS; van den Hoogen FHJ; den Broeder AA; Wenink MH
Trials; 2020 Feb; 21(1):155. PubMed ID: 32041657
[TBL] [Abstract][Full Text] [Related]
10. [Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative"].
De Leonardis F; Alivernini S; Bonacci E; Buono AM; Bombardieri S; Ferraccioli GF; Montecucco C; Sinigaglia L; Trotta F; Valentini G
Reumatismo; 2010; 62(1):34-45. PubMed ID: 20390116
[TBL] [Abstract][Full Text] [Related]
11. Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.
Goulabchand R; Mouterde G; Barnetche T; Lukas C; Morel J; Combe B
Ann Rheum Dis; 2014 Feb; 73(2):414-9. PubMed ID: 23355079
[TBL] [Abstract][Full Text] [Related]
12. [Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis].
Canhão H; Santos MJ; Costa L; Bogas M; Mourão AF; Machado P; Fonseca JE; Silva JA;
Acta Reumatol Port; 2009; 34(1):78-95. PubMed ID: 19377402
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review.
Maese J; Díaz Del Campo P; Seoane-Mato D; Guerra M; Cañete JD
Reumatol Clin (Engl Ed); 2018; 14(2):81-89. PubMed ID: 28089501
[TBL] [Abstract][Full Text] [Related]
14. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Boyce EG; Halilovic J; Stan-Ugbene O
Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
[TBL] [Abstract][Full Text] [Related]
15. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate.
García-Vicuña R; Martín-Martínez MA; Gonzalez-Crespo MR; Tornero-Molina J; Fernández-Nebro A; Blanco-García FJ; Blanco-Alonso R; Marsal-Barril S;
Reumatol Clin; 2017; 13(3):127-138. PubMed ID: 27825791
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in psoriatic arthritis.
Cutolo M; Seriolo B; Pizzorni C; Craviotto C; Sulli A
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S76-80. PubMed ID: 12463453
[TBL] [Abstract][Full Text] [Related]
17. Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis.
den Braanker H; Wervers K; Mus AMC; Bangoer PS; Davelaar N; Luime J; Tchetverikov I; Hazes JMW; Vis M; Lubberts E; Kok MR
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32669451
[TBL] [Abstract][Full Text] [Related]
18. Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritis.
Paccou J; Wendling D
Joint Bone Spine; 2015 Mar; 82(2):80-5. PubMed ID: 24997741
[TBL] [Abstract][Full Text] [Related]
19. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.
Visser K; Katchamart W; Loza E; Martinez-Lopez JA; Salliot C; Trudeau J; Bombardier C; Carmona L; van der Heijde D; Bijlsma JW; Boumpas DT; Canhao H; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Murphy G; Østergaard M; Pereira IA; Ramos-Remus C; Valentini G; Zochling J; Dougados M
Ann Rheum Dis; 2009 Jul; 68(7):1086-93. PubMed ID: 19033291
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature.
Behrens F; Cañete JD; Olivieri I; van Kuijk AW; McHugh N; Combe B
Rheumatology (Oxford); 2015 May; 54(5):915-26. PubMed ID: 25349441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
